ZAP70 and B-cell chronic lymphocytic leukemia: Patients with mutated IGHV or few CD38+ or ZAP-70+ B cells generally exhibit the indolent course, whereas patients with CLL cells presenting few or no IGHV gene mutations or numerous CD38+ or ZAP-70+ B cells exhibit an aggressive disease [3-5].